... L.P. acquired a new position in shares of CymaBay Therapeutics in the 2nd quarter valued at about $242,000. Finally, Ardsley Advisory Partners lifted its stake in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners ...
http://ift.tt/2wzrIc7
No comments:
Post a Comment